MedCath Corporation Reports First Quarter Earnings CHARLOTTE, N.C.,
Feb. 3 /PRNewswire-FirstCall/ -- MedCath Corporation (NASDAQ:MDTH),
a healthcare provider focused on the diagnosis and treatment of
cardiovascular disease, today announced its operating results for
its first fiscal quarter, which ended December 31, 2004. First
quarter highlights: -- Net revenue increased 19.1% -- Adjusted
EBITDA rose 41.4% -- Same facility hospital net revenue increased
9.4% -- Same facility adjusted admissions increased 8.6% First
Quarter 2005 Results MedCath's net revenue increased 19.1% to
$184.8 million in the first quarter of fiscal 2005 from $155.1
million in the first quarter of fiscal 2004. Income from operations
was $15.1 million in the first quarter of fiscal 2005, compared to
$7.9 million in the first quarter of fiscal 2004. Adjusted EBITDA
increased 41.4% to $25.2 million from $17.8 million and income from
continuing operations was $2.6 million, or $0.14 per diluted share,
in the first quarter of fiscal 2005, compared to income from
continuing operations $765,000, or $0.04 per diluted share, in the
first quarter of fiscal 2004. Net income for the quarter, including
the results of The Heart Hospital of Milwaukee, which is accounted
for as discontinued operations, totaled $4.5 million, or $0.24 per
diluted share compared to net loss of $933,000, or $0.05 per share
in the first quarter of fiscal 2004. During the first quarter of
fiscal 2005, MedCath sold the assets of The Heart Hospital of
Milwaukee and closed the facility's operations. For the first
fiscal quarter of 2005, MedCath's results include income from
discontinued operations, net of taxes, of $1.9 million. Income from
discontinued operations includes a gain on sale of the assets, less
operating losses, facility closing costs and other related charges.
"During the first quarter, we continued to benefit from management
initiatives that were established over the past year," said John T.
Casey, MedCath's chairman and chief executive officer. "We are now
well positioned for long-term growth and are actively pursuing
joint venture opportunities that will be beneficial to MedCath."
Operating Statistics and Cash Flow Hospital admissions for the
first quarter of fiscal 2005 increased 13.6% and adjusted
admissions rose 18.2% from the first quarter of the previous fiscal
year. Hospital division net revenue increased 22.4%. Same facility
admissions increased 3.0%, adjusted admissions increased 8.6%,
inpatient catheterization procedures increased 9.6% and inpatient
surgical procedures increased 9.0%, which contributed to the
increase in same facility hospital division net revenue of 9.4%
during the quarter versus the prior year. Cash flow from operations
totaled $9.8 million in the first quarter of fiscal 2005 in
comparison to $6.3 million in the first quarter of fiscal 2004. Use
of Non-GAAP Financial Measures This release contains measures of
MedCath's historical financial performance that are not calculated
and presented in conformity with generally accepted accounting
principles ("GAAP"), including Adjusted EBITDA. Adjusted EBITDA
represents MedCath's income from continuing operations before
interest expense; interest income; taxes; depreciation;
amortization; gain or loss on disposal of property, equipment and
other assets; other income, net; equity in net earnings of
unconsolidated affiliates; and minority interest. MedCath's
management uses Adjusted EBITDA to measure the performance of the
company's various operating entities, to compare actual results to
historical and budgeted results, and to make capital allocation
decisions. Management provides Adjusted EBITDA to investors to
assist them in performing their analysis of MedCath's historical
operating results. Further, management believes that many investors
in MedCath also invest in, or have knowledge of, other healthcare
companies that use Adjusted EBITDA as a financial performance
measure. Because Adjusted EBITDA is a non-GAAP measure, Adjusted
EBITDA, as defined above, may not be comparable to other similarly
titled measures of other companies. MedCath has included a
supplemental schedule with the financial statements that accompany
this press release that reconciles historical Adjusted EBITDA to
MedCath's income from continuing operations. Management will
discuss and answer questions regarding MedCath's quarterly results
today during a 10 a.m. ET conference call. In the United States,
you may participate by dialing (877) 697-5351. International
callers should dial (706) 634-0602. The conference ID for both
domestic and international callers is "MedCath." A live webcast
will also be available on the company's web site,
http://www.medcath.com/. This information will be available on the
web site on or immediately following the conference call for 30
days. A recorded replay of the call will be available until 11:59
p.m. ET, February 10, 2005. To access the replay, domestic callers
should dial (800) 642-1687 and international callers should dial
(706) 645-9291. The archived conference ID is 3211353. This press
release and the financial information included therewith will be
accessible on the web, by going to http://www.medcath.com/,
"Investor Relations," then clicking on "News." MedCath Corporation,
headquartered in Charlotte, N.C., is a healthcare provider focused
on the diagnosis and treatment of cardiovascular disease. While
each of its majority-owned hospitals is licensed as a general acute
care hospital, MedCath focuses on serving the unique needs of
patients suffering from cardiovascular disease. Together with its
physician partners who own equity interests in them, MedCath
currently owns and operates twelve hospitals with a total of 727
licensed beds, located in Arizona, Arkansas, California, Louisiana,
New Mexico, Ohio, South Dakota, and Texas. In addition to its
hospitals, MedCath provides cardiovascular care services in
diagnostic and therapeutic facilities located in various states and
through mobile cardiac catheterization laboratories. Parts of this
announcement contain forward-looking statements that involve risks
and uncertainties. Although management believes that these
forward-looking statements are based on reasonable assumptions,
these assumptions are inherently subject to significant economic,
regulatory and competitive uncertainties and contingencies that are
difficult or impossible to predict accurately and are beyond our
control. Actual results could differ materially from those
projected in these forward-looking statements. We do not assume any
obligation to update these statements in a news release or
otherwise should material facts or circumstances change in ways
that would affect their accuracy. These various risks and
uncertainties are described in detail in Exhibit 99.1 to our Annual
Report on Form 10-K filed with the Securities and Exchange
Commission on December 14, 2004. A copy of this report, including
exhibits, is available on the Internet site of the Commission at
http://www.sec.gov/. These risks and uncertainties include, among
others, the impact of the Medicare Prescription Drug Improvement
Act of 2003 and other healthcare reform initiatives, possible
reductions or changes in reimbursements from government or third
party payors that would decrease our revenue, greater than
anticipated losses at new hospitals during the ramp up period, a
negative finding by a regulatory organization with oversight of one
of our hospitals, and changes in medical or other technology and
reimbursement rates for new technologies. MEDCATH CORPORATION
CONSOLIDATED STATEMENTS OF OPERATIONS (In thousands, except per
share data) (Unaudited) Three Months Ended December 31, 2004 2003
Net revenue $184,760 $155,123 Operating expenses: Personnel expense
57,213 47,012 Medical supplies expense 52,486 41,977 Bad debt
expense 11,484 13,788 Other operating expenses 38,400 31,520
Pre-opening expenses - 3,016 Depreciation 9,736 9,723 Amortization
290 290 (Gain)/loss on disposal of property, equipment and other
assets 3 (84) Total operating expenses 169,612 147,242 Income from
operations 15,148 7,881 Other income (expenses): Interest expense
(7,998) (6,320) Interest income 390 231 Other income, net 5 4
Equity in net earnings of unconsolidated affiliates 769 577 Total
other expenses, net (6,834) (5,508) Income from continuing
operations before minority interest, income taxes and discontinued
operations 8,314 2,373 Minority interest share of earnings of
consolidated subsidiaries (3,999) (1,091) Income from continuing
operations before income taxes and discontinued operations 4,315
1,282 Income tax expense 1,723 517 Income from continuing
operations 2,592 765 Income (loss) from discontinued operations,
net of taxes 1,948 (1,698) Net income (loss) $4,540 $(933) Earnings
(loss) per share, basic Continuing operations $0.14 $0.04
Discontinued operations 0.11 (0.09) Earnings (loss) per share,
basic $0.25 $(0.05) Earnings (loss) per share, diluted Continuing
operations $0.14 $0.04 Discontinued operations 0.10 (0.09) Earnings
(loss) per share, diluted $0.24 $(0.05) Weighted average number of
shares, basic 18,045 17,949 Dilutive effect of stock options 932 -
Weighted average number of shares, diluted 18,977 17,949 MEDCATH
CORPORATION SELECTED OPERATING DATA (In thousands, except per share
data and selected operating data) (Unaudited) Three Months Ended
December 31, 2004 2003 % Change Statement of Operations Data: Net
revenue $184,760 $155,123 19.1% Adjusted EBITDA (1) $25,177 $17,810
41.4% Income from operations $15,148 $7,881 92.2% Income from
continuing operations $2,592 $765 238.8% Earnings per share from
continuing operations, basic $0.14 $0.04 237.0% Earnings per share
from continuing operations, diluted $0.14 $0.04 220.5% (1) See
Supplemental Financial Disclosure--Reconciliation of Non-GAAP
Financial Measures to GAAP Financial Measures. Three Months Ended
December 31, 2004 2003 % Change Selected Operating Data
(consolidated) (a): Number of hospitals 11 10 Licensed beds (b) 672
580 Staffed and available beds (c) 631 524 Admissions (d) 10,891
9,588 13.6% Adjusted admissions (e) 14,293 12,093 18.2% Patient
days (f) 37,158 34,088 9.0% Adjusted patient days (g) 48,393 42,944
12.7% Average length of stay (days) (h) 3.41 3.56 (4.2)% Occupancy
(i) 64.0% 70.7% Inpatient catheterization procedures 5,808 4,654
24.8% Inpatient surgical procedures 2,775 2,322 19.5% Hospital
division revenue $171,229 $139,930 22.4% Three Months Ended
December 31, 2004 2003 % Change Selected Operating Data (same
facility): Number of hospitals 9 9 Licensed beds (b) 580 580
Staffed and available beds (c) 547 524 Admissions (d) 9,874 9,588
3.0% Adjusted admissions (e) 13,129 12,093 8.6% Patient days (f)
33,344 34,088 (2.2)% Adjusted patient days (g) 44,049 42,944 2.6%
Average length of stay (days) (h) 3.38 3.56 (5.1)% Occupancy (i)
66.3% 70.7% Inpatient catheterization procedures 5,100 4,654 9.6%
Inpatient surgical procedures 2,531 2,322 9.0% Hospital division
revenue $153,069 $139,930 9.4% (a) Selected operating data includes
consolidated hospitals in operation as of the end of the period but
does not include hospitals which were accounted for using the
equity method in our consolidated financial statements. (b)
Licensed beds represent the number of beds for which the
appropriate state agency licenses a facility regardless of whether
the beds are actually available for patient use. (c) Staffed and
available beds represent the number of beds that are readily
available for patient use at the end of the period. (d) Admissions
represent the number of patients admitted for inpatient treatment.
(e) Adjusted admissions is a general measure of combined inpatient
and outpatient volume. We computed adjusted admissions by dividing
gross patient revenue by gross inpatient revenue and then
multiplying the quotient by admissions. (f) Patient days represent
the total number of days of care provided to inpatients. (g)
Adjusted patient days is a general measure of combined inpatient
and outpatient days. We computed adjusted patient days by dividing
gross patient revenue by gross inpatient revenue and then
multiplying the quotient by patient days. (h) Average length of
stay (days) represents the average number of days inpatients stay
in our hospital. (i) We computed occupancy by dividing patient days
by the number of days in the period and then dividing the quotient
by the number of staffed and available beds. MEDCATH CORPORATION
SUPPLEMENTAL FINANCIAL DISCLOSURE - RECONCILIATION OF NON-GAAP
FINANCIAL MEASURES TO GAAP FINANCIAL MEASURES (Unaudited) The
following table reconciles Adjusted EBITDA with MedCath's income
from continuing operations as derived directly from MedCath's
consolidated financial statements for the three months ended
December 31, 2004 and 2003. Three Months Ended December 31, 2004
2003 (in thousands) Income from continuing operations $2,592 $765
Add: Income tax expense 1,723 517 Minority interest share of
earnings of consolidated subsidiaries 3,999 1,091 Equity in net
earnings of unconsolidated affiliates (769) (577) Other income, net
(5) (4) Interest income (390) (231) Interest expense 7,998 6,320
(Gain)/loss on disposal of property, equipment and other assets 3
(84) Amortization 290 290 Depreciation 9,736 9,723 Adjusted EBITDA
$25,177 $17,810 DATASOURCE: MedCath Corporation CONTACT: John T.
Casey, Chairman/Chief Executive Officer, or James E. Harris, Chief
Financial Officer, both of MedCath, +1-704-708-6600 Web site:
http://www.medcath.com/
Copyright
Medcath (NASDAQ:MDTH)
Historical Stock Chart
From Jun 2024 to Jul 2024
Medcath (NASDAQ:MDTH)
Historical Stock Chart
From Jul 2023 to Jul 2024